Ambuja Cements (AMBUJACEM) — Corporate Action

Ambuja Cements Limited scheduled a shareholders meeting for December 30, 2025, to approve an amalgamation with subsidiary Penna Cement Industries Limited (99.94% owned since August 2024). The scheme, under NCLT direction, requires statutory majority approval. Shareholders excluding Ambuja will receive ₹321.50 per share in cash. Remote e-voting runs December 26-29, 2025. The merger consolidates 7.3 MTPA clinker and 10.0 MTPA cement capacity, achieving cost reductions and operational synergies. Combined pre-merger net worth stands at ₹51,935 crore.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AMBUJACEM ✨ Ask AI About This

About Ambuja Cements Limited (AMBUJACEM)

Construction Materials · Cement & Cement Products · Listed on NSE

Market Cap: ₹1,07,215.34 Cr P/E: 23.3 ROE: 7.7% ROCE: 4.6%

View full AMBUJACEM stock details →

📡 Get AI alerts when AMBUJACEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMBUJACEM — Free

💡 Ask AI about this filing

"How does this corporate action affect Ambuja Cements Limited's outlook?" "What did Ambuja Cements Limited announce on 26 November 2025?" "Is this positive or negative for AMBUJACEM?"

Ask AI Free →

📊 More AMBUJACEM filings

See all AMBUJACEM filings →

🔥 Also filed on 26 November 2025

AXISBANK Axis Bank Limited Corporate Action TATASTEEL Tata Steel Limited Announcement OBEROIRLTY Oberoi Realty Limited Announcement KOTAKBANK Kotak Mahindra Bank Limited Voting Results COLPAL Colgate Palmolive (India) Limited Board Meeting AXISBANK Axis Bank Limited Board Meeting

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMBUJACEM files new disclosures

Track AMBUJACEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.